The CDC recommends a single dose of any FDA-approved ... including results from the full 2023–2024 RSV season in the FDA-CMS ...
"While currently approved protein-based RSV vaccines are safe & effective when given as an initial dose, critical gaps persist globally: (1) suboptimal boostability for revaccination when ...